Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

25
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
25
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

31
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

26
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
26
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

1.1K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

836
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
836
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

47
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The junctional protein associated with coronary artery disease predicts adverse cardiovascular events in patients with acute coronary syndromes at high residual risk.

European heart journal·2025
Same author

IL-6 in the spotlight: From cardiovascular pathophysiology to therapy.

European journal of clinical investigation·2025
Same author

Comprehensive venous outflow is the optimal venous score in predicting functional outcome in acute ischemic stroke patients.

European journal of clinical investigation·2025
Same author

Beyond triglycerides lowering: rethinking the role of eicosapentaenoic acid in lipoprotein biology.

Cardiovascular research·2025
Same author

Is metabolically healthy obesity shaped by inflammation, gender differences, and fat distribution?

World journal of cardiology·2025
Same author

Influence of medical educational background on the diagnostic quality of ChatGPT-4 responses in internal medicine: A pilot study.

European journal of clinical investigation·2025

Related Experiment Video

Updated: Aug 29, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.2K

Physical activity to reduce PCSK9 levels.

Amedeo Tirandi1, Fabrizio Montecucco1,2, Luca Liberale1,2

  • 1First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.

Frontiers in Cardiovascular Medicine
|September 12, 2022
PubMed
Summary
This summary is machine-generated.

Regular physical activity (PA) may lower PCSK9 levels, a key factor in cholesterol regulation. This review explores how exercise impacts PCSK9, benefiting cardiovascular health and preventing atherosclerosis.

Keywords:
cardiovascularexerciseinflammationphysical activityproprotein convertase subtilisin/kexin type 9

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.5K
Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
07:59

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

9.7K

Related Experiment Videos

Last Updated: Aug 29, 2025

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9
08:14

A High-Throughput Luciferase Assay to Evaluate Proteolysis of the Single-Turnover Protease PCSK9

Published on: August 28, 2018

8.2K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.5K
Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads
07:59

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

9.7K

Area of Science:

  • Cardiology
  • Metabolic Health
  • Exercise Physiology

Background:

  • Decreased physical activity (PA) is linked to adverse lipid profiles and increased cardiovascular disease (CVD) risk.
  • Regular PA improves cardiovascular health by favorably modulating metabolism.
  • Proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates low-density lipoprotein cholesterol (LDL-C) levels; PCSK9 inhibitors are effective in CVD prevention.

Purpose of the Study:

  • To review current research on the regulatory role of PA in PCSK9 plasma levels.
  • To highlight the impact of regular exercise on PCSK9 and its implications for atherosclerosis and cardiovascular health.

Main Methods:

  • Literature review of recent studies investigating the relationship between physical activity and PCSK9.
  • Analysis of proposed mechanisms by which PA influences lipoprotein metabolism and PCSK9 expression.

Main Results:

  • Emerging evidence suggests PA acts as a negative modulator of PCSK9.
  • Reduced PCSK9 levels due to PA may contribute to lower circulating LDL-C.
  • Further research is needed to fully elucidate the extent and mechanisms of PA's effect on PCSK9.

Conclusions:

  • Physical activity shows potential as a non-pharmacological strategy to manage PCSK9 levels.
  • Regular exercise may offer a beneficial role in preventing atherosclerosis and improving overall cardiovascular health.
  • Understanding PA's modulation of PCSK9 could lead to enhanced CVD prevention strategies.